Showing results (1051-1060 of 1,133) with videos related to

Sort By:
Pageof 114
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 22, 2025
Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced MelanomaSaskia de Groot, Hedwig M Blommestein, Brenda Leeneman, et al.
Cancer|January 10, 2024
BRAF/MEK inhibitor rechallenge in advanced melanoma patientsOlivier J Van Not, Alfons J M van den Eertwegh, John B Haanen, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 25, 2018
[Recent treatment results for metastatic melanoma: data from the Dutch Melanoma Treatment Registry]Michiel C T van Zeijl, Alfons J M van den Eertwegh, Michel W J M Wouters, et al.
American Journal of Clinical Oncology|December 17, 2020
Nationwide Outcomes of Advanced Melanoma According to BRAFV600 StatusJesper van Breeschoten, Michel W J M Wouters, Liesbeth C de Wreede, et al.
British Journal of Cancer|January 26, 2021
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysisJesper van Breeschoten, Michel W J M Wouters, Doranne L Hilarius, et al.
ESMO Open|December 2, 2021
Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugsM G Franken, B Leeneman, M J B Aarts, et al.
JCO Precision Oncology|September 21, 2022
BRAF and NRAS Mutation Status and Response to Checkpoint Inhibition in Advanced MelanomaOlivier J van Not, Willeke A M Blokx, Alfons J M van den Eertwegh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2025
Induction therapy with BRAF/MEK inhibitors versus upfront ipilimumab/nivolumab in poor prognostic advanced melanomaM Bloem, A J M van den Eertwegh, J B A G Haanen, et al.
Multiple Sclerosis and Related Disorders|June 15, 2026
Real world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosisP C G Molenaar, D L Weir, E P J Arnoldus, et al.
BJS Open|March 23, 2023
Impact of complications after resection of pancreatic cancer on disease recurrence and survival, and mediation effect of adjuvant chemotherapy: nationwide, observational cohort studyAnne Claire Henry, Jelle C van Dongen, Iris W J M van Goor, et al.
Pageof 114